Gynecologic Cancer
From the Journals
One-month delay in cancer treatment linked to increase in mortality
The risk of death varied by treatment type.
Conference Coverage
IMRT new standard of care for high-risk cervical cancer
Intensity-modulated radiotherapy was as effective as three-dimensional conformal radiotherapy but was associated with significantly less morbidity...
Perspectives
New technologies aim to improve ovarian cancer detection
Commentary
A guide to the new agents reshaping ovarian cancer treatment
Conference Coverage
SRS instead of WBRT for patients with multiple brain metastases
Conference Coverage
Cancer therapy affects sexual health in most patients
Opinion
Are uterine manipulators safe for gynecologic cancer surgery?
Prospective studies are needed to determine if use of these instruments truly is safe or not.
Guidelines
ASCO advises against PARP inhibitor retreatment in ovarian cancer
ASCO guidelines detail recommendations for PARP inhibitor treatment in ovarian cancer.
From the Journals
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients
The NCI-MATCH trial has led to new clinical trial benchmarks, according to the study chair.
Conference Coverage
Lower BP and better tumor control with drug combo?
Feature
Are oncologists ready to confront a second wave of COVID-19?